GMP Nucleic Acid Raw Materials Market
完整報告名稱與涵蓋範圍
GMP Nucleic Acid Raw Materials Market Size, Share & Trends Analysis Report, By Material Type (Nucleotides and Cap Analogs, Enzymes and Enzyme Mixes, Plasmid DNA and Linearized Templates, Lipids and Formulation Excipients, Buffers, Purification Consumables and Reference Standards), By Application (mRNA Vaccines and Therapeutics, Gene Therapy and Gene Editing, Oligonucleotide Therapeutics, Cell Therapy Manufacturing), By Grade (GMP Grade, GMP-Ready and Research Grade Transitioning to GMP), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The GMP nucleic acid raw materials market covers the aggregate supply of manufacturing-grade inputs for nucleic acid-based medicines, including nucleotides and cap analogs, enzymes, plasmid and linearized DNA templates, lipids and formulation excipients, buffers, purification consumables and reference standards, used in mRNA, gene therapy, gene editing, oligonucleotide and cell therapy manufacturing. Component-level markets are analysed in dedicated InsightAce studies; this study quantifies the combined raw material pool and its supply chain dynamics.
Raw materials account for a large share of nucleic acid drug substance cost, and their availability, quality and regulatory documentation determine program timelines. The pandemic exposed single-source dependencies for cap analogs, modified nucleotides and lipids, prompting sponsors to demand dual sourcing, suppliers to build GMP capacity and regulators to clarify expectations for ancillary and critical raw materials. Suppliers are integrating portfolios to offer template-to-lipid bundles with harmonised quality systems, while Asian manufacturers have entered with cost-competitive GMP products. Demand is diversifying from vaccines to therapeutic mRNA, in vivo editing and cell therapy, changing the product mix toward plasmid templates, editing reagents and specialty lipids.
North America and Europe dominate consumption and premium supply, with China, South Korea and Japan expanding both production and demand. Competition involves diversified life science suppliers, nucleic acid specialists, lipid and excipient manufacturers and plasmid producers.
The InsightAce study supplies US$ forecasts for all material type, application, grade and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global GMP Nucleic Acid Raw Materials Market Snapshot
Chapter 4. Global GMP Nucleic Acid Raw Materials Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Material Type Estimates & Trend Analysis
5.1. Material Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Material Type:
5.2.1. Nucleotides and Cap Analogs
5.2.2. Enzymes and Enzyme Mixes
5.2.3. Plasmid DNA and Linearized Templates
5.2.4. Lipids and Formulation Excipients
5.2.5. Buffers, Purification Consumables and Reference Standards
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. Application & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
6.2.1. mRNA Vaccines and Therapeutics
6.2.2. Gene Therapy and Gene Editing
6.2.3. Oligonucleotide Therapeutics
6.2.4. Cell Therapy Manufacturing
Chapter 7. Market Segmentation 3: By Grade Estimates & Trend Analysis
7.1. Grade & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Grade:
7.2.1. GMP Grade
7.2.2. GMP-Ready and Research Grade Transitioning to GMP
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Nucleic Acid Therapeutics Developers
8.2.2. CDMOs
8.2.3. Academic and Government Manufacturing Centers
Chapter 9. GMP Nucleic Acid Raw Materials Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Thermo Fisher Scientific Inc.
11.2. Merck KGaA (MilliporeSigma)
11.3. Danaher Corporation (Aldevron, Cytiva)
11.4. TriLink BioTechnologies (Maravai LifeSciences)
11.5. Hongene Biotech Corporation
11.6. Roche CustomBiotech
11.7. New England Biolabs, Inc.
11.8. Sartorius AG
11.9. Avantor, Inc.
11.10. Evonik Industries AG
11.11. CordenPharma International
11.12. Charles River Laboratories International, Inc.
11.13. Bio-Techne Corporation
11.14. VGXI, Inc.
11.15. Genscript ProBio
圖表清單 List of Tables & Figures
Table 1. Global GMP Nucleic Acid Raw Materials Market Revenue Forecast by Material Type, 2026-2035 (US$ Mn)
Figure 1. Global GMP Nucleic Acid Raw Materials Market Segmentation Overview
Table 2. Global GMP Nucleic Acid Raw Materials Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 2. Global GMP Nucleic Acid Raw Materials Market Share by Material Type, 2026 & 2035
Table 3. Global GMP Nucleic Acid Raw Materials Market Revenue Forecast by Grade, 2026-2035 (US$ Mn)
Figure 3. Raw Material Cost Contribution Across mRNA, Gene Therapy and Oligonucleotide Manufacturing
Table 4. Global GMP Nucleic Acid Raw Materials Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global GMP Nucleic Acid Raw Materials Market Share by Application, 2026 & 2035
Table 5. North America GMP Nucleic Acid Raw Materials Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Supply Chain Risk Map for Critical Nucleic Acid Raw Materials
Table 6. Europe GMP Nucleic Acid Raw Materials Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific GMP Nucleic Acid Raw Materials Growth Opportunity Analysis
Table 7. Asia Pacific GMP Nucleic Acid Raw Materials Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Integrated Raw Material Portfolios Offered by Leading Suppliers
Table 8. Latin America GMP Nucleic Acid Raw Materials Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key GMP Nucleic Acid Raw Materials Market Participants
Table 9. Middle East & Africa GMP Nucleic Acid Raw Materials Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們